% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Butt:144762,
author = {J. A. Butt$^*$ and M. Jenab and M. Pawlita$^*$ and K.
Overvad and A. Tjonneland and A. Olsen and M.-C.
Boutron-Ruault and F. Carbonnel and F. R. Mancini and R.
Kaaks$^*$ and T. Kühn$^*$ and H. Boeing and A. Trichopoulou
and A. Karakatsani and D. Palli and V. M. Pala and R. Tumino
and C. Sacerdote and S. Panico and B. Bueno-de-Mesquita and
C. H. van Gils and R. C. H. Vermeulen and E. Weiderpass and
J. R. Quirós and E. J. Duell and M.-J. Sánchez and M.
Dorronsoro and J. M. Huerta and E. Ardanaz and B. Van
Guelpen and S. Harlid and A. Perez-Cornago and M. J. Gunter
and N. Murphy and H. Freisling and D. Aune and T.
Waterboer$^*$ and D. J. Hughes},
title = {{A}ntibody {R}esponses to {F}usobacterium nucleatum
{P}roteins in {P}rediagnostic {B}lood {S}amples are not
{A}ssociated with {R}isk of {D}eveloping {C}olorectal
{C}ancer.},
journal = {Cancer epidemiology, biomarkers $\&$ prevention},
volume = {28},
number = {9},
issn = {1538-7755},
address = {Philadelphia, Pa.},
publisher = {AACR},
reportid = {DKFZ-2019-02194},
pages = {1552 - 1555},
year = {2019},
note = {#EA:F022#},
abstract = {There is a lack of prospective data on the potential
association of Fusobacterium nucleatum (F. nucleatum) and
colorectal cancer risk. In this study, we assessed whether
antibody responses to F. nucleatum are associated with
colorectal cancer risk in prediagnostic serum samples in the
European Prospective Investigation into Nutrition and Cancer
(EPIC) cohort.We applied a multiplex serology assay to
simultaneously measure antibody responses to 11 F. nucleatum
antigens in prediagnostic serum samples from 485 colorectal
cancer cases and 485 matched controls. Conditional logistic
regression models were used to estimate odds ratios (ORs)
and $95\%$ confidence intervals (CI).We observed neither a
statistically significant colorectal cancer risk association
for antibodies to individual F. nucleatum proteins nor for
combined positivity to any of the 11 proteins (OR, 0.81;
$95\%$ CI, 0.62-1.06).Antibody responses to F. nucleatum
proteins in prediagnostic serum samples from a subset of
colorectal cancer cases and matched controls within the EPIC
study were not associated with colorectal cancer risk.Our
findings in prospectively ascertained serum samples
contradict the existing literature on the association of F.
nucleatum with colorectal cancer risk. Future prospective
studies, specifically detecting F. nucleatum in stool or
tissue biopsies, are needed to complement our findings.},
cin = {F022 / F020 / C020},
ddc = {610},
cid = {I:(DE-He78)F022-20160331 / I:(DE-He78)F020-20160331 /
I:(DE-He78)C020-20160331},
pnm = {316 - Infections and cancer (POF3-316)},
pid = {G:(DE-HGF)POF3-316},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:31481495},
doi = {10.1158/1055-9965.EPI-19-0313},
url = {https://inrepo02.dkfz.de/record/144762},
}